Crohn's disease laboratory findings: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
Line 84: | Line 84: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
Line 92: | Line 95: | ||
[[Category:Conditions diagnosed by stool test]] | [[Category:Conditions diagnosed by stool test]] | ||
[[Category:Abdominal pain]] | [[Category:Abdominal pain]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 21:10, 29 July 2020
Crohn's disease |
Diagnosis |
---|
Treatment |
Case Studies |
Crohn's disease laboratory findings On the Web |
American Roentgen Ray Society Images of Crohn's disease laboratory findings |
Risk calculators and risk factors for Crohn's disease laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
The laboratory findings in a patient with Crohn's disease include anemia, low albumin, elevated ESR, elevated serum alkaline phosphatase, deranged LFTs and electrolyte abnormalities
Laboratory Findings
Electrolyte and Biomarker Studies
- A complete blood count may reveal anemia, which may be caused either by blood loss or [[Cyanocobalamin|vitamin BTemplate:Ssub]] deficiency. The latter may be seen with ileitis because vitamin BTemplate:Ssub is absorbed in the ileum.[1] It is also true in patients with ilectomy done in response to the complication. Another cause of anemia is anemia of chronic disease, characterized by its microcytic and hypochromic anemia. There are reasons in anemia, including medication in treatment of inflammatory bowel disease like azathioprine that can lead to cytopenia and sulfasalazine, which can also result in folate malabsorption, etc.
- Erythrocyte sedimentation rate, or ESR, and C-reactive protein measurements can also be useful to gauge the degree of inflammation.[2]
- Testing for anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) has been evaluated to identify inflammatory diseases of the intestine[3] and to differentiate Crohn's disease from ulcerative colitis.[4]
Laboratory tests | Findings |
---|---|
CBC | |
Iron studies | |
Serum Vit B12 |
|
[null Serum folate] |
|
CMP | |
CRP and ESR |
|
Stool testing |
|
Yersinia serology |
|
Diagnostic criteria
Diagnosis of Crohn's disease is based on endoscopic findings and Crohns activity index score.
Endoscopic findings
Three major endoscopic findings are specific for the diagnosis of CD.
- Aphthous ulcers
- Cobblestoning
- Discontinuous lesions (skip areas)
CD activity index
Eight factors, each summed up for a weighting score:
- Number of liquid or soft stools each day for 7 days x2
- Abdominal pain (graded from 0-3 on severity) each day for 7 days x5
- General wellbeing, subjectively assessed from 0 (well) to 4 (terrible) each day for 7 days x7
- Presence of complications, 1 point for each x20:
- Arthralgia or arthritis
- Iritis or uveitis
- Presence of erythema nodosum, pyoderma granulosum, or aphthous ulcers
- Anal fissures, fistulae, or abscesses
- Fever during the past 7 days
- Taking antidiarrheal medications x30
- Presence of an abdominal mass (0 as none, 2 as questionable, 5 as definite) x10
- Hematocrit <0.47 in men and <0.42 in women x6
- Percentage deviation from standard weight x1.
- Index values of 150 and below are associated with quiescent disease; values above that indicate active disease, and values above 450 are seen with extremely severe disease.
References
- ↑ Goh, Jason (2003). "Review article: nutrition and adult inflammatory bowel disease". Alimentary Pharmacology & Therapeutics. 17 (3): 307–20. doi:10.1046/j.1365-2036.2003.01482.x. PMID 12562443. Unknown parameter
|coauthors=
ignored (help); Unknown parameter|month=
ignored (help) - ↑ Chamouard, Patrick (April). "Diagnostic Value of C-Reactive Protein for Predicting Activity Level of Crohn's Disease". Clinical Gastroenterology and Hepatology. doi:10.1016/j.cgh.2006.02.003. PMID 16630759. Unknown parameter
|coauthors=
ignored (help); Unknown parameter|month=
ignored (help); Check date values in:|year=
(help) Epub ahead of print - ↑ Kaila, B. (2005). "The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease". The Canadian Journal of Gastroenterology. 19 (12): 717–21. PMID 16341311. Retrieved 2006-07-02. Unknown parameter
|month=
ignored (help); Unknown parameter|coauthors=
ignored (help) - ↑ Israeli, E. (2005). "Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease". Gut. 54 (9): 1232–6. doi:10.1136/gut.2004.060228. PMID 16099791. Unknown parameter
|coauthors=
ignored (help); Unknown parameter|month=
ignored (help)